Asia-Pacific Diabetes Devices Market Analysis - Global Industry, Size, Share, Trends and Forecast, 2014 – 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC242

The Asia-Pacific diabetes devices market was valued at $3.5 billion in 2016 and is expected to witness a growth around 6% during the forecast period of 2017 to 2024. Diabetes is a metabolic disorder that occurs due to high sugar levels in blood, which are caused by either defect in body’s ability to produce sufficient amount of insulin or incapability of body cells to respond to insulin. Based on the cause of development, diabetes is classified into three types, including Type 1 diabetes (pancreas stops producing insulin), Type 2 diabetes (body cells do not respond to the insulin) and Type 3 gestational diabetes (which occurs in pregnant women). Among these, Type 2 diabetes is the most common form of diabetes, occurring approximately 90% of total patients. Type 1 diabetes is usually diagnosed in children and young adults, which has been treated by injection of insulin. Type 2 diabetes commonly affects older adults and youth; however, it can be initially managed with exercise and diet. During the course of time, most patients need oral medication for the treatment. The International Diabetes Federation (IDF) estimated that the number of diabetes patients would reach to around 640 million by 2040 from 415 million in 2015. In addition, IDF estimated that the global healthcare expenditure on diabetes care would surpass $802 billion by 2040 from $673 billion in 2015, which represents 12% of the overall healthcare spending. 
 
The Asia-Pacific diabetes devices market is segmented based on the type of device. Based on type of device, the market is segmented into monitoring devices (SMBG and CGM), and treatment devices (manual insulin injection devices and pumps). This research report is designed to analyze and estimate the performance, market demand, and size of the Asia-pacific diabetes devices market. This report includes historical data and forecasts, along with the information on market size, value chain, product sales, pipeline products and various other key factors that are boosting or impeding the growth of this market. The major factors driving this market include rising awareness about the advanced treatment products, increasing number of patients with diabetes, growing demand for minimally invasive and non-invasive treatment options, technological advancements, and improving healthcare infrastructure in the emerging markets. In addition, growing supportive government policies and increasing demand from the emerging countries are further expected to drive the market growth.
 
Currently, the cost associated with diabetes-related procedures/treatment is enormous and continuously growing. Globally, North America has the highest diabetes healthcare expenditure, while Africa has the lowest expenditure among all the regions. The combined diabetes spending in the United States, China and Germany, contributed to almost 60% of global healthcare expenditure on diabetes, which accounts for only 35% of total diabetes population. Whereas, the country (India) with second highest number of diabetes population across the globe, spent only 3% of total expenditure on diabetes. Considering all these factors, there is a huge growth and market opportunity in emerging markets for the companies operating in this market. 
 
The company profile section include detailed analysis of some of the key players such as Abbott Laboratories, AstraZeneca plc, B. Braun Melsungen AG, Bayer HealthCare AG, Becton, Dickinson and Company, Johnson & Johnson, Medtronic, Roche, DexCom, Insulet, Sanofi, and Novo Nordisk.
 


Related Reports

Cancer Biomarkers Market By Type (Protein, Genetic, Others), By Technology (Omics Technology, Immunoassay, Imaging Technology, Cytogenetic Testing), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Leukemia, Thyroid gland Cancer, Kidney Cancer, Bladder Cancer, Others), By Application (Diagnosis, Prognosis, Research, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global cancer biomarkers market size is expected to reach around US$ 29.8 Bn by 2026 and will grow at noteworthy CAGR of around 11.9% over the forecast period 2019 to 2026. Cancer biomarker is a substance that helps to indicate the presence of cancer in the body. This substance may be a molecule secreted by a tumor or specific response of the body to a tumor. Genetic, proteomic

4D Printing in Healthcare Market By Component(Equipment, Software & Services, Programmable Materials), By Technology (PolyJet, FDM, Stereolithography, SLS), By Application (Patient Specific Implant, Medical Research Models, Surgical Guides), By End User (Hospitals, Dental Laboratories, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global 4D printing in healthcare market size is expected to reach around US$ 34.1 Mn by 2026 growing at a CAGR of around 29.6% over the forecast period 2019 to 2026. 4D printing is the latest technology in healthcare that is going to revolutionize the artificial organs and prosthetics industry. 4D printing is a product of collaboration work between MIT’s Lab and Stratasys. 4D printing is evolved 3D p

Healthcare Consulting Services Market By Type of Service (IT Consulting, Digital consulting, Financial Consulting, Operation Consulting, Strategy Consulting, HR & Talent Consulting), By End User (Life Science Companies, Hospitals, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare consulting services market size is expected to reach around US$ 22.8 Bn by 2026 and growing at a CAGR of around 9.8% over the forecast period 2019 to 2026. Healthcare consultancy service providers advice life science companies, government bodies, hospitals, insurance companies, and research institutes about business strategies. Digital consulting, financial consulting, operations consulta

Healthcare Analytics Market By Application (Financial, Clinical, Population Health Analytics, Operational & administrative), By Type (Descriptive, Predictive, Prescriptive, Cognitive), By Deployment Mode (On-premise, On-demand), By End-User (Payer, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare analytics market size is expected to hit around US$ 52.2 Bn by 2026 and will grow at a CAGR of around 23.4% over the forecast period 2019 to 2026. Healthcare analytics are the solutions that involve all the healthcare analysis activities by using data from the key areas of the healthcare: pharmaceutical and R&D data, patient behaviors data, clinical data, and claims & cost data. H

Electronic Health Record Market By Product (Web-based, Client Server-based), By Type (Ambulatory, Acute, Post-Acute), By End Use (Ambulatory Care, Hospitals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global electronic health record market size is expected to reach over US$ 30 Bn by 2026 and is anticipated to grow at a CAGR over 5.5% in terms of revenue during the forecasting period from 2019 to 2026. EMRs refer to both individual patient documents and usually to systems that retain patient documents and serve as data entry interfaces and test ordering, other processes and p

Medical Electronics Market By Application (Imaging, Therapeutics, Patient Monitoring, Homecare/Handheld Products), By End Use (Hospital, Ambulatory Surgical Centers, Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global medical electronics market value is expected to surpass US$ 122 Bn by 2026 and is anticipated to grow at a CAGR of around 6% in terms of revenue during the forecast period from 2019 to 2026. Medical electronics refer to a certain category of electronic instruments and equipment specifically used for medical application such as diagnosis, treatment, study, control of anes

Cart Summary